Forbes January 24, 2025
William A. Haseltine

Gene editing is now reaching the mainstream, ushering in a new era of genetic manipulation. Traditionally, inserting or deleting entire genes, regulating their expression, and altering specific sequences of significant genes have been performed as separate processes. However, a new development has emerged that allows these three critical changes to be made simultaneously, significantly enhancing the capabilities of gene therapies.

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, activation, and repression into a single, compact system. Much like a Swiss Army knife, mvGPT is a marvel of compact engineering—a genetic powerhouse of versatility and precision. As highlighted in a study by Rice University, the potential of mvGPT, especially when used alongside...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
PBMs push private-label biosimilars in 2025 formularies
CAR T-Cell Pioneer Plots Technology’s Next Steps
Eli Lilly Adds Alzheimer’s Care to Digital Health Platform Services
GLP-1 drug use for weight loss has soared, costing billions

Share This Article